Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COX20 Cox2 chaperone homolog pseudogene
- Molecular classification
- Pseudogene, Processed pseudogene (likely; processed pseudogenes arise from reverse-transcribed mRNA, lack introns, and can be transcribed as non-coding RNA)
01
Overview
The COX20 Cox2 chaperone homolog pseudogene (ENSG00000267084) is a nonfunctional genomic sequence with high homology to the protein-coding COX20 gene, which is an essential mitochondrial chaperone that assists in the assembly of cytochrome c oxidase (complex IV) in the respiratory chain[1][3][7]. Pseudogenes like ENSG00000267084 arise from mutations, duplications, or retrotransposition events, and although they do not encode proteins, they may play indirect regulatory roles at the RNA level (e.g., interacting with microRNAs as ceRNAs)[2][6], but there is no evidence that this pseudogene acts as a drug target, biomarker, or is directly involved in disease processes. The functional significance of the vast majority of pseudogenes, including the COX20 pseudogene, remains poorly defined, and most pseudogenes are considered noncoding genomic elements without direct therapeutic relevance[2][4][5][6].
- Other names
- COX20PCOX20P2COX20 pseudogeneCOX20 Cox2 chaperone homolog pseudogene
02
Biological functions
Other (Pseudogenes do not encode proteins; some may act as long non-coding RNAs, participate in regulatory networks such as competing endogenous RNA [ceRNA], but direct functional evidence for every specific pseudogene is usually lacking. No protein function.)
03
Disease associations
Other (Pseudogenes can be involved in regulation of gene expression in disease, but there is no established disease association for COX20 pseudogenes. Functional COX20 can be implicated in mitochondrial diseases, but not the pseudogene itself.)
Beyond the preview
Go deeper on COX20 Cox2 chaperone homolog pseudogene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on COX20 Cox2 chaperone homolog pseudogene.